CHMP recommends EU conditional approval of Roche’s potential first-in-class bispecific antibody mosunetuzumab for people with relapsed or refractory follicular lymphoma
If approved, mosunetuzumab would be the first CD20xCD3 T-cell engaging bispecific antibody available to treat follicular lymphoma (FL) offering a new, off-the-shelf, fixed-duration treatment option The recommendation is based on the GO29781 study where mosunetuzumab induced high complete response rates, with the majority of complete responses lasting for at least 18 months in people with […]
Virtual Press Conference on COVID-19 and other global health issues
Good morning, good afternoon and good evening. On COVID-19, there’s good news. Last week, the lowest number of COVID-19 deaths was recorded since the early days of the pandemic. However, some countries are still witnessing serious spikes in cases, which is putting pressure on hospitals. And our ability to monitor trends is compromised as testing […]
Statement on the eleventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic
Members and Advisors of the Emergency Committee were convened by videoconference. The Director-General welcomed the Committee members and advisers. The Director-General explained that the world has tools to limit transmission, save lives, and protect health systems. He expressed hope in the current epidemiological situation, noting that the world is currently experiencing the lowest number of […]
WHO delivers 20 ambulances to Ukraine
To support emergency health needs in Ukraine, World Health Organization (WHO) today gave 20 all-terrain ambulances able to function in even the most damaged and inaccessible areas to the Ministry of Health of Ukraine. “We bring not just supplies but support based on your needs. Today we are handing to you 20 ambulances, along with […]
WHO records 100th attack on health care in Ukraine
A grim milestone has been crossed today in the war in Ukraine – more than 100 attacks on health care verified by WHO since the start of the war on February 24. The attacks so far have claimed 73 lives and injured 51. Of the current total of 103 attacks, 89 have impacted health facilities […]
WHO Director-General, World Health Day Joint Press Conference with US HHS Secretary Becerra, Washington
Joint Hybrid Press Conference with the US Department of Health and Human Services (HHS) Secretary Xavier Becerra on World Health Day, Washington DC, United States of America (as delivered) Thank you, Secretary Becerra, and good afternoon everyone. I also thank Assistant Secretary for Global Affairs Loyce Pace and Assistant Secretary for Public Affairs Sarah Lovenheim. […]
WHO public hearings regarding a new international instrument on pandemic preparedness and response: “The World Together”
Following the 1 April announcement, we are pleased to inform you that the first round of public hearings regarding a new international instrument on pandemic preparedness and response will occur on 12 and 13 April 2022. These public hearings will be comprised of a spoken component (through videoconferencing software) and a written component (through a […]
WHO urges accelerated action to protect human health and combat the climate crisis at a time of heightened conflict and fragility
6 April 2022, Geneva – On this World Health Day (April 7, 2022), WHO is issuing an urgent call for accelerated action by leaders and all people to preserve and protect health and mitigate the climate crisis as part of an “Our planet, our health” campaign marking the organization’s founding day, which falls at a […]
Ad hoc announcement pursuant to Art. 53 LR Roche provides update on phase III SKYSCRAPER-02 study in extensive-stage small cell lung cancer
SKYSCRAPER-02, the first randomized study of tiragolumab in extensive stage small-cell lung cancer (ES-SCLC), did not meet its co-primary endpoint of progression-free survival ES-SCLC is a hard-to-treat disease and Tecentriq plus chemotherapy remains a standard of care Tiragolumab continues to be evaluated in non-small cell lung cancer (NSCLC) and other cancer types through additional phase […]
Egypt and Nigeria medicines regulators achieve high maturity level in WHO classification and WHO launches list of regulatory authorities that meet international standards
Today, WHO announced that Egypt’s and Nigeria’s medical products regulatory agencies had reached maturity level 3. This means that these national bodies have been found to function well and that they could be eligible for inclusion into the transitional WHO Listed Authorities, a list that will comprise the world’s regulators of reference – that is, […]
